Supplementary Table S3 from A Model of Intratumor and Interpatient Heterogeneity Explains Clinical Trials of Curative Combination Therapy for Lymphoma
Year: 2025
Type: supplementary-materials
Abstract: Table S3. All digitized data included in manuscript. All data are in DLBCL patients, and all data are PFS unless otherwise noted. Data is publicly available in Code Ocean capsule.
Authors: Amy E. Pomeroy, Adam C. Palmer
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4410099219
